Want to see IN:ZYDUSWELL full AI Analyst Report?
ZYDUSWELL Stock Chart & Stats
₹424.90
-₹21.60(-1.10%)
At close: 4:00 PM EST
₹424.90
-₹21.60(-1.10%)
Day’s Range― - ―
52-Week Range₹357.55 - ₹610.95
Previous CloseN/A
Volume6.77K
Average Volume (3M)15.16K
Market Cap
₹183.59B
Enterprise Value₹166.44K
Total Cash (Recent Filing)₹1.15B
Total Debt (Recent Filing)₹32.03B
Price to Earnings (P/E)93.2
Beta0.82
Next Earnings
Nov 14, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend Yield0.21%
Share Statistics
EPS (TTM)6.20
Shares Outstanding318,160,700
10 Day Avg. Volume9,092
30 Day Avg. Volume15,161
Financial Highlights & Ratios
PEG Ratio-1.59
Price to Book (P/B)2.33
Price to Sales (P/S)3.42
P/FCF Ratio345.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.6
Revenue Forecast (FY)₹53.29B
Bulls Say, Bears Say
Bulls Say
Strong Revenue AccelerationA 37.9% top-line surge in FY2026 indicates sustained demand and successful go-to-market execution. Durable revenue momentum supports scale advantages, funds brand building and innovation, and provides a buffer to restore margins over multiple quarters if cost control improves.
Diversified Branded PortfolioA multi-category branded portfolio (oral care, nutrition, personal care) provides structural resilience via category diversification and repeat-purchase behavior. This reduces reliance on any single product cycle and supports steady cash flow from everyday consumer demand.
Sizable Equity BufferA large equity base (~₹58.3B) gives long-term balance-sheet capacity to absorb temporary leverage increases and fund strategic investments. It underpins solvency, supports creditor confidence, and provides room for selective M&A or working-capital flexibility over the medium term.
Bears Say
Sharp Margin CompressionMaterial margin decline reflects either cost pressure, pricing/mix deterioration, or higher operating costs; such compression erodes returns on capital and long-term profitability. If structural, weaker margins limit reinvestment capacity and make earnings more sensitive to sales volatility.
Weakened Cash GenerationSignificant decline in operating and free cash flow signals working-capital stress or higher cash costs. Persistent weaker cash generation reduces internal funding for marketing, capex and dividends, increasing reliance on external financing and constraining strategic optionality over coming quarters.
Rising LeverageA rapid jump in debt-to-equity reduces financial flexibility and raises interest and refinancing risk. Even with sizable equity, the step-up from near-zero leverage materially changes the capital structure and limits the company's ability to pursue opportunistic investments or absorb future shocks.
Zydus Wellness Limited News
ZYDUSWELL FAQ
What was Zydus Wellness Limited’s price range in the past 12 months?
Zydus Wellness Limited lowest stock price was ₹357.55 and its highest was ₹610.95 in the past 12 months.
What is Zydus Wellness Limited’s market cap?
Zydus Wellness Limited’s market cap is ₹183.59B.
When is Zydus Wellness Limited’s upcoming earnings report date?
Zydus Wellness Limited’s upcoming earnings report date is Nov 14, 2026 which is in 99 days.
How were Zydus Wellness Limited’s earnings last quarter?
Zydus Wellness Limited released its earnings results on Aug 04, 2026. The company reported ₹3.7 earnings per share for the quarter, missing the consensus estimate of ₹3.933 by -₹0.233.
Is Zydus Wellness Limited overvalued?
According to Wall Street analysts Zydus Wellness Limited’s price is currently Overvalued.
Does Zydus Wellness Limited pay dividends?
Zydus Wellness Limited pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 0.21%. See more information on Zydus Wellness Limited dividends here
What is Zydus Wellness Limited’s EPS estimate?
Zydus Wellness Limited’s EPS estimate is 0.4.
How many shares outstanding does Zydus Wellness Limited have?
Zydus Wellness Limited has 318,160,700 shares outstanding.
What happened to Zydus Wellness Limited’s price movement after its last earnings report?
Zydus Wellness Limited reported an EPS of ₹3.7 in its last earnings report, missing expectations of ₹3.933. Following the earnings report the stock price went down -1.894%.
Which hedge fund is a major shareholder of Zydus Wellness Limited?
Currently, no hedge funds are holding shares in IN:ZYDUSWELL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zydus Wellness Limited
Zydus Wellness Limited is an Indian firm dedicated to the creation, manufacturing, promotion, and distribution of health and wellness products. Their extensive product range encompasses popular sugar substitutes such as Sugar Free Gold, Sugar Free Natura, and Sugar Free Green. The company also offers well-known beverages like Complan, a milk-based health drink, and Glucon D, a glucose-infused refreshment, alongside Sugarlite, a unique blend of sugar and stevia. In the personal care segment, Zydus Wellness markets the Everyuth brand, featuring skincare items such as soap-free face washes, masks, scrubs, and cleansers. The Nycil brand provides solutions for prickly heat, cooling powders, and hand sanitizers. Furthermore, their Nutralite line includes a diverse array of spreads, from probiotic butter and table spreads to ghee, butter, cholesterol-fat-free spreads, mayonnaise, and chocolate spreads. Beyond its domestic operations in India, Zydus Wellness actively exports its offerings. Tracing its origins to 1988, the Ahmedabad, India-based entity was initially known as Carnation Nutra Analogue Foods Limited before adopting its current name, Zydus Wellness Limited, in January 2009. It operates as a subsidiary of Cadila Healthcare Limited.
Technical Analysis
Adani Wilmar Limited
―
Britannia Industries Ltd
―
Nestle India Ltd.
―
Patanjali Foods Limited
―
Tata Consumer Products Limited
―